This book deals with the symposium held in Jakarta on calcium antagonist therapy which was sponsored by Bayer AG on the calcium antagonist drug Nifedipine. This drug is used extensively in the Asian Pacific area for the treatment of hypertension, a common disease in this region, and also for ischaemic heart disease. It details both basic pharmacology and research studies in the Asian Pacific region in the field of hypertension and ischaemic heart disease and as such is of considerable interest to cardiologists in the region.